Vault-13

Stonepine Capital Management, LLC

Bend, OR · CIK 1440771 · 13F filing filed 2022-08-12

SEC-registered investment adviser since 2026 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Bend, OR (main office)United States United Statesabout 1
Sausalito, CA2 officesUnited States United States2

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$214.9m reported value -10.9% vs Q1 2022
25positions
74.4%in top 10
4 new 12 added 8 reduced 7 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 AMRYT PHARMA PLC SPONSORED ADS SPONSORED ADS 6,298,348 $44.0m20.48% 20.48% ReducedShares held: Q3 2021 5.8m, Q4 2021 6.1m, Q1 2022 6.3m, Q2 2022 6.3m -39.9k -39,852 -0.6%
2 CTI BIOPHARMA CORP COM COM 3,681,195 $22.0m10.23% 10.23% ReducedShares held: Q3 2021 8.0m, Q4 2021 8.8m, Q1 2022 4.7m, Q2 2022 3.7m -1.0m -1,003,209 -21.4%
3 XERIS BIOPHARMA HOLDINGS INC COM XERS XERS 11,647,417 $17.9m8.35% 8.35% AddedShares held: Q3 2021 0, Q4 2021 5.7m, Q1 2022 7.9m, Q2 2022 11.6m +3.7m +3,723,361 47.0%
4 ADMA BIOLOGICS INC COM ADMA ADMA 7,000,000 $13.9m6.45% 6.45% ReducedShares held: Q3 2021 0, Q4 2021 9.9m, Q1 2022 7.1m, Q2 2022 7.0m -131.8k -131,808 -1.9%
5 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 8,853,763 $13.2m6.14% 6.14% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 4.9m, Q2 2022 8.9m +3.9m +3,941,049 80.2%
6 QUIDELORTHO CORP COM QDEL QDEL 119,787 $11.6m5.42% 5.42% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 119.8k
7 REZOLUTE INC COM NEW RZLT RZLT 3,001,926 $9.7m4.51% 4.51% AddedShares held: Q3 2021 0, Q4 2021 808.4k, Q1 2022 748.7k, Q2 2022 3.0m +2.3m +2,253,224 300.9%
8 OPTINOSE INC COM COM 2,616,515 $9.6m4.46% 4.46% ReducedShares held: Q3 2021 0, Q4 2021 3.8m, Q1 2022 2.9m, Q2 2022 2.6m -309.9k -309,901 -10.6%
9 UROGEN PHARMA LTD COM URGN URGN 1,111,050 $9.1m4.23% 4.23% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 268.8k, Q2 2022 1.1m +842.2k +842,217 313.3%
10 LIGAND PHARMACEUTICALS INC COM NEW LGND LGND 100,244 $8.9m4.16% 4.16% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 73.7k, Q2 2022 100.2k +26.5k +26,544 36.0%
11 AFFIMED N V COM COM 3,143,773 $8.7m4.05% 4.05% NewShares held: Q3 2021 1.2m, Q4 2021 0, Q1 2022 0, Q2 2022 3.1m
12 APOLLO ENDOSURGERY INC COM COM 2,161,999 $7.9m3.67% 3.67% AddedShares held: Q3 2021 912.1k, Q4 2021 1.2m, Q1 2022 1.7m, Q2 2022 2.2m +468.2k +468,165 27.6%
13 OVID THERAPEUTICS INC COM OVID OVID 3,487,928 $7.5m3.49% 3.49% ReducedShares held: Q3 2021 3.3m, Q4 2021 4.0m, Q1 2022 4.2m, Q2 2022 3.5m -730.1k -730,141 -17.3%
14 EXAGEN INC COM XGN XGN 1,260,387 $7.2m3.37% 3.37% AddedShares held: Q3 2021 390.6k, Q4 2021 858.6k, Q1 2022 1.1m, Q2 2022 1.3m +139.3k +139,347 12.4%
15 CASTLE BIOSCIENCES INC COM CSTL CSTL 295,372 $6.5m3.02% 3.02% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 295.4k
16 CONFORMIS INC COM CFMS CFMS 17,304,350 $6.1m2.85% 2.85% AddedShares held: Q3 2021 487.0k, Q4 2021 14.8m, Q1 2022 17.3m, Q2 2022 17.3m +23.0k +22,964 0.1%
17 DIAMEDICA THERAPEUTICS INC COM NEW DMAC DMAC 1,176,344 $2.4m1.11% 1.11% ReducedShares held: Q3 2021 165.8k, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m -20.9k -20,901 -1.8%
18 AERIE PHARMACEUTICALS INC COM AERI AERI 251,235 $1.9m0.88% 0.88% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 93.9k, Q2 2022 251.2k +157.3k +157,335 167.6%
19 OPIANT PHARMACEUTICALS INC COM OPNT OPNT 152,278 $1.8m0.85% 0.85% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 152.3k
20 ATYR PHARMA INC COM NEW ATYR ATYR 601,580 $1.7m0.79% 0.79% UnchangedShares held: Q3 2021 410.5k, Q4 2021 525.5k, Q1 2022 601.6k, Q2 2022 601.6k
21 MARINUS PHARMACEUTICALS INC COM NEW MRNS MRNS 242,327 $1.2m0.55% 0.55% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 56.7k, Q2 2022 242.3k +185.6k +185,580 327.0%
22 XOMA ROYALTY CORPORATION COM NEW XOMA XOMA 45,910 $1.0m0.48% 0.48% AddedShares held: Q3 2021 68.5k, Q4 2021 46.0k, Q1 2022 36.8k, Q2 2022 45.9k +9.1k +9,107 24.8%
23 ANI PHARMACEUTICALS INC COM ANIP ANIP 28,800 $854.0k0.40% 0.40% AddedShares held: Q3 2021 0, Q4 2021 52.3k, Q1 2022 26.1k, Q2 2022 28.8k +2.7k +2,740 10.5%
24 SYNLOGIC INC COM COM 92,746 $107.0k0.05% 0.05% ReducedShares held: Q3 2021 1.0m, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 92.7k -971.4k -971,389 -91.3%
25 CIDARA THERAPEUTICS INC COM COM 208,443 $102.0k0.05% 0.05% ReducedShares held: Q3 2021 782.8k, Q4 2021 2.3m, Q1 2022 2.5m, Q2 2022 208.4k -2.3m -2,288,077 -91.7%

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
ANTARES PHARMA INC ATRS ATRS 3,130,192 $12.8m3.1m shares
ENANTA PHARMACEUTICALS INC ENTA ENTA 119,972 $8.5m120.0k shares
QUIDEL CORP QDEL QDEL 61,791 $6.9m61.8k shares
EVOLUS INC EOLS EOLS 586,224 $6.6m586.2k shares
SURGALIGN HOLDINGS INC RTIX RTIX 7,375,678 $2.2m7.4m shares
CELCUITY INC CELC CELC 239,433 $2.2m239.4k shares
NEUROONE MED TECHNOLOGIES CO 248,105 $273.0k248.1k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
QUOIN PHARMACEUTICALS LTD QNRX · 13G · filed 2026-05-15 QNRX 10.0% -0.6 pts 13G 2026-05-15
AEON BIOPHARMA INC AEON · 13G · filed 2026-07-21 AEON 9.9%≈ $3.9m new 13G 2026-07-21
AZITRA INC 13G · filed 2026-06-22 9.9% new 13G 2026-06-22
ELOXX PHARMACEUTICALS INC ELOX · 13G · filed 2026-06-16 ELOX 9.9%≈ $5.6m new 13G 2026-06-16
SINTX TECHNOLOGIES INC SINT · 13G · filed 2026-06-09 SINT 9.9%≈ $1.2m new 13G 2026-06-09
CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-05-15 CNSP 9.9%≈ $760.7k +2.0 pts 13G 2026-05-15
CELLECTAR BIOSCIENCES INC CLRB · 13G · filed 2026-05-11 CLRB 9.9%≈ $2.4m new 13G 2026-05-11
CURIS INC 13G · filed 2026-03-27 9.9%≈ $2.1m new 13G 2026-03-27
IN8BIO INC INAB · 13G · filed 2025-12-22 INAB 9.9%≈ $1.4m new 13G 2025-12-22
AYTU BIOPHARMA INC AYTU · 13G · filed 2025-08-13 AYTU 9.9%≈ $1.9m 13G 2025-08-13
OPTINOSE INC OPTN · 13G · filed 2025-05-14 OPTN 7.8% +1.9 pts 13G 2025-05-14
FEMASYS INC FEMY · 13G · filed 2026-08-31 FEMY 7.2%≈ $2.6m new 13G 2026-08-31
EDESA BIOTECH INC EDSA · 13G · filed 2026-08-26 EDSA 6.9%≈ $5.9m +6.6 pts 13G 2026-08-26
CALCIMEDICA INC 13G · filed 2026-08-25 6.0%≈ $2.2m +1.4 pts 13G 2026-08-25
TELA BIO INC TELA · 13G · filed 2025-02-13 TELA 6.0%≈ $1.8m 13G 2025-02-13
PASITHEA THERAPEUTICS CORP KTTA · 13G · filed 2026-06-23 KTTA 5.8%≈ $1.0m new 13G 2026-06-23